Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2010, Vol. 4 Issue (1) : 21-28     DOI: 10.1007/s11684-010-0013-x
Research articles |
Genetics of ischemic and hemorrhagic stroke in Chinese population
Wei-Li ZHANG MD, PhD1,Ru-Tai HUI MD, PhD2,
1.Sino-German Laboratory for Molecular Medicine, the Key Laboratory for Clinical Cardiovascular Genetics, Beijing 100037, China; 2.Sino-German Laboratory for Molecular Medicine, the Key Laboratory for Clinical Cardiovascular Genetics, Beijing 100037, China;Hypertension Division, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China;
Download: PDF(126 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  Stroke is a major cause of adult death and disability worldwide. Epidemiological and animal studies have provided strong evidence that the pathogenesis of stroke is multi-factorial and induced by a combination of environmental and genetic risk factors, but the identification of individual causative variants remains little known. Genetic influences are likely to be polygenic with small effect sizes, and stroke itself consists of a number of different subtypes which may each have different genetic profiles. In addition, various ethnic populations may have different stroke risk, such as Asian race. The reasons for high risk of stroke among the Chinese, especially hemorrhagic stroke, remain unknown. Most human studies have taken a candidate gene approach using case-control methodology. To be reliably detected, small relative risks require large sample sizes, probably 1000 patients or more. Genome-wide association (GWA) study is an unbiased and comprehensive approach to identify common risk alleles for complex diseases. Recently, a multistage GWA study has identified three loci on chromosomes 2q, 8q and 9p to be associated with intracranial aneurysm in European and Japanese populations. Another GWA finding is the identification of risk variants for cardioembolic stroke on chromosome 4q25 in European populations. In this review, we mainly focus on the results from case-control association studies on genetic factors that play a role in the risk of ischemic and hemorrhagic stroke in Chinese population. The combined effects of multiple susceptibility genes for stroke risk are also summarized.
Keywords genetics      ischemic stroke      hemorrhagic stroke      association study      
Issue Date: 05 March 2010
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-010-0013-x     OR     http://academic.hep.com.cn/fmd/EN/Y2010/V4/I1/21
Liu M, Wu B, Wang W Z, Lee L M, Zhang S H, Kong L Z. Stroke in China: epidemiology, prevention, and managementstrategies. Lancet Neurol, 2007, 6 (5): 456–464

doi: 10.1016/S1474-4422(07)70004-2
Reed D M. The paradox of high risk of stroke in populations withlow risk of coronary heart disease. AmJ Epidemiol, 1990, 131(4): 579–588
Flossmann E, Schulz U G, Rothwell P M. Systematic review of methodsand results of studies of the genetic epidemiology of ischemic stroke. Stroke, 2004, 35(1): 212–227

doi: 10.1161/01.STR.0000107187.84390.AA
Adams H P Jr, Bendixen B H, Kappelle L J, Biller J, Love B B, Gordon D L. Classification of subtype of acute ischemicstroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993, 24(1): 35–41
Schulz U G, Flossmann E, Rothwell P M. Heritability of ischemicstroke in relation to age, vascular risk factors, and subtypes ofincident stroke in population-based studies. Stroke, 2004, 35(4): 819–824

doi: 10.1161/01.STR.0000121646.23955.0f
Jerrard-Dunne P, Cloud G, Hassan A, Markus H S. Evaluating the genetic component of ischemic stroke subtypes: a familyhistory study. Stroke, 2003, 34(6): 1364–1369

doi: 10.1161/01.STR.0000069723.17984.FD
Qureshi A I, Tuhrim S, Broderick J P, Batjer H H, Hondo H, Hanley D F. Spontaneous intracerebral hemorrhage. N Engl J Med, 2001, 344(19): 1450–1460

doi: 10.1056/NEJM200105103441907
Healy D G. Case-control studies in the genomic era: a clinician’sguide. Lancet Neurol, 2006, 5(8): 701–707

doi: 10.1016/S1474-4422(06)70524-5
Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Ma A, Han Y, Wang Y, Shi Y, Ye J, Hui R. Elevated plasmahomocysteine was associated with hemorrhagic and ischemic stroke,but methylenetetrahydrofolate reductase gene C677T polymorphism wasa risk factor for thrombotic stroke: a Multicenter Case-Control Studyin China. Stroke, 2003, 34(9): 2085–2090

doi: 10.1161/01.STR.0000086753.00555.0D
Wald D S, Law M, Morris J K. Homocysteine and cardiovascular disease:evidence on causality from a meta-analysis. BMJ, 2002, 325(7374): 1202

doi: 10.1136/bmj.325.7374.1202
Kang S S, Zhou J, Wong P W, Kowalisyn J, Strokosch G. Intermediate homocysteinemia:a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet, 1988, 43(4): 414–421
Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-Hashi Y, Kitamura K, Yazaki Y. Methylenetetrahydrofolate reductase gene polymorphismand ischemic stroke in Japanese. ArteriosclerThromb Vasc Biol, 1998, 18(9): 1465–1469
Zhang W, Sun K, Chen J, Liao Y, Qin Q, Ma A, Wang D, Zhu Z, Wang Y, Hui R. High plasma homocysteinelevels contribute to the risk of stroke recurrence and all-cause mortalityin a large prospective stroke population. Clin Sci (Lond), 2010, 118(3): 187–194

doi: 10.1042/CS20090142
Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X. Efficacyof folic acid supplementation in stroke prevention: a meta-analysis. Lancet, 2007, 369(9576): 1876–1882

doi: 10.1016/S0140-6736(07)60854-X
Zhao C X, Cui Y H, Fan Q, Wang P H, Hui R, Cianflone K, Wang D W. Small denselow-density lipoproteins and associated risk factors in patients withstroke. Cerebrovasc Dis, 2009, 27(1): 99–104

doi: 10.1159/000175768
Brazier L, Tiret L, Luc G, Arveiler D, Ruidavets J B, Evans A, Chapman J, Cambien F, Thillet J. Sequence polymorphisms in the apolipoprotein(a) geneand their association with lipoprotein(a) levels and myocardial infarction:the ECTIM Study. Atherosclerosis, 1999, 144(2): 323–333

doi: 10.1016/S0021-9150(98)00333-5
Peng D Q, Zhao S P, Wang J L. Lipoprotein(a) and apolipoprotein E epsilon4 as independent risk factors for ischemic stroke. J Cardiovasc Risk, 1999, 6(1): 1–6
Scholz M, Kraft H G, Lingenhel A, Delport R, Vorster E H, Bickeboller H, Utermann G. Geneticcontrol of lipoprotein(a) concentrations is different in Africansand Caucasians. Eur J Hum Genet, 1999, 7(2): 169–178

doi: 10.1038/sj.ejhg.5200290
Sandholzer C, Hallman D M, Saha N, Sigurdsson G, Lackner C, Csaszar A, Boerwinkle E, Utermann G. Effectsof the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentrationin 7 ethnic groups. Hum Genet, 1991, 86(6): 607–614

doi: 10.1007/BF00201550
Trommsdorff M, Kochl S, Lingenhel A, Kronenberg F, Delport R, Vermaak H, Lemming L, Klausen I C, Faergeman O, Utermann G. Apentanucleotide repeat polymorphism in the 5' control region of theapolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrationsin Caucasians. J Clin Invest, 1995, 96(1): 150–157

doi: 10.1172/JCI118015
Sun L, Li Z, Zhang H, Ma A, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Zhang Z, Wang W, Hui R. PentanucleotideTTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a)are associated with ischemic and hemorrhagic stroke in Chinese: amulticenter case-control study in China. Stroke, 2003, 34(7): 1617–1622

doi: 10.1161/01.STR.0000078370.12085.02
Wang Y, Zhen Y, Shi Y, Chen J, Zhang C, Wang X, Yang X, Zheng Y, Liu Y, Hui R. Vitamin K epoxide reductase:a protein involved in angiogenesis. MolCancer Res, 2005, 3(6): 317–323

doi: 10.1158/1541-7786.MCR-04-0221
Rieder M J, Reiner A P, Gage B F, Nickerson D A, Eby C S, McLeod H L, Blough D K, Thummel K E, Veenstra D L, Rettie A E. Effect of VKORC1 haplotypes on transcriptional regulation and warfarindose. N Engl J Med, 2005, 352(22): 2285–2293

doi: 10.1056/NEJMoa044503
Wang Y, Zhang W, Zhang Y, Yang Y, Sun L, Hu S, Chen J, Zhang C, Zheng Y, Zhen Y, Sun K, Fu C, Yang T, Wang J, Sun J, Wu H, Glasgow W C, Hui R. VKORC1 haplotypes are associatedwith arterial vascular diseases (stroke, coronary heart disease, andaortic dissection). Circulation, 2006, 113(12): 1615–1621

doi: 10.1161/CIRCULATIONAHA.105.580167
Moulton K S. Angiogenesis in atherosclerosis: gathering evidence beyondspeculation. Curr Opin Lipidol, 2006, 17(5): 548–555

doi: 10.1097/01.mol.0000245261.71129.f0
Celletti F L, Waugh J M, Amabile P G, Brendolan A, Hilfiker P R, Dake M D. Vascular endothelial growth factor enhances atheroscleroticplaque progression. Nat Med, 2001, 7(4): 425–442

doi: 10.1038/86490
Cleaver O, Melton D A. Endothelial signaling during development. Nat Med, 2003, 9(6): 661–668

doi: 10.1038/nm0603-661
Zhang W, Sun K, Zhen Y, Wang D, Wang Y, Chen J, Xu J, Hu F B, Hui R. VEGFreceptor-2 variants are associated with susceptibility to stroke andrecurrence. Stroke, 2009, 40(8): 2720–2726

doi: 10.1161/STROKEAHA.109.554394
Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, Qin Q, Zhao B, Yang Y, Hui R. Polymorphisms of KDR geneare associated with coronary heart disease. J Am Coll Cardiol, 2007, 50(8): 760–767

doi: 10.1016/j.jacc.2007.04.074
Chen J, Yu H, Song W, Sun K, Song Y, Lou K, Yang T, Zhang Y, Hui R. Angiopoietin-2promoter haplotypes confer an increased risk of stroke in a ChineseHan population. Clin Sci (Lond), 2009, 117(11): 387–395

doi: 10.1042/CS20090035
Vallance P and Leiper J. Cardiovascularbiology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolasepathway. Arterioscler Thromb Vasc Biol, 2004, 24(6): 1023–1030

doi: 10.1161/01.ATV.0000128897.54893.26
Bai Y, Chen J, Sun K, Xin Y, Liu J, Hui R. Common genetic variation in DDAH2 is associated withintracerebral haemorrhage in a Chinese population: a multi-centrecase-control study in China. Clin Sci (Lond), 2009, 117(7): 273–279

doi: 10.1042/CS20090005
Song Q, Cole J W, O'Connell J R, Stine O C, Gallagher M, Giles W H, Mitchell B D, Wozniak M A, Stern B J, Sorkin J D, McArdle P F, Naj A C, Xu Q, Gibbons G H, Kittner S J. Phosphodiesterase 4D polymorphismsand the risk of cerebral infarction in a biracial population: thestroke prevention in young women study. Hum Mol Genet, 2006, 15(16): 2468–2478
Xue H, Wang H, Song X, Li W, Sun K, Zhang W, Wang X, Wang Y, Hui R. Phosphodiesterase4D gene polymorphism is associated with ischaemic and haemorrhagicstroke. Clin Sci (Lond), 2009, 116(4): 335–340
Zhang W L, Yang X M, Shi J, Sun K, Hui R T. Polymorphism of SG13S114T/Ain the ALOX5AP gene and the risk for stroke in a large Chinese cohort. Yi Chuan Xue Bao, 2006, 33(8): 678–684 (in Chinese)
Wang Q, Ding H, Tang J R, Zhang L, Xu YJ, Yan JT, Wang W, Hui R T, Wang CY, Wang D W. C-reactive protein polymorphismsand genetic susceptibility to ischemic stroke and hemorrhagic strokein the Chinese Han population. Acta PharmacolSin, 2009, 30(3): 291–298
Song W, Chen J, Sun K, Yu H, Hui R. No association of PLIN polymorphismswith hemorrhagic and ischemic stroke. Stroke, 2008, 39(2): 470–472
Zhang L, Ding H, Yan J, Hui R, Wang W, Kissling G E, Zeldin D C, Wang D W. Genetic variation in cytochromeP450 2J2 and soluble epoxide hydrolase and risk of ischemic strokein a Chinese population. PharmacogenetGenomics, 2008, 18(1): 45–51
Zhang L, Zhang H, Sun K, Song Y, Hui R, Huang X. The 825C/T polymorphism of G-protein beta3 subunit geneand risk of ischaemic stroke. J Hum Hypertens, 2005, 19(9): 709–714
Ritchie M D, Hahn L W, Roodi N, Bailey L R, Dupont W D, Parl F F, Moore J H. Multifactor-dimensionalityreduction reveals high order interactions among estrogen-metabolismgenes in sporadic breast cancer. Am J HumGenet, 2001, 69(1): 138–147
Shen C D, Zhang W L, Sun K, Wang Y B, Zhen Y S, Hui R T. Interaction of genetic risk factors confers higher riskfor thrombotic stroke in male Chinese: a multicenter case-controlstudy. Ann Hum Genet, 2007, 71(Pt 5): 620–629
Liu J, Sun K, Bai Y, Zhang W, Wang X, Wang Y, Wang H, Chen J, Song X, Xin Y, Liu Z, Hui R. Associationof three-gene interaction among MTHFR, ALOX5AP and NOTCH3 with thromboticstroke: a multicenter case-control study. Hum Genet, 2009, 125(5,6): 649–656
Kim I, Saunders T L, Morrison S J. Sox17 dependence distinguishesthe transcriptional regulation of fetal from adult hematopoietic stemcells. Cell, 2007, 130(3): 470–483

doi: 10.1016/j.cell.2007.06.011
Janzen V, Forkert R, Fleming H E, Saito Y, Waring M T, Dombkowski D M, Cheng T, DePinho R A, Sharpless N E, Scadden D T. Stem-cell ageing modified by the cyclin-dependent kinaseinhibitor p16INK4a. Nature, 2006, 443(7110): 421–426
Pollex R L, Hegele R A. Copy number variation in the human genome and its implications forcardiovascular disease. Circulation, 2007, 115(24): 3130–3138

doi: 10.1161/CIRCULATIONAHA.106.677591
Rieder M J, Reiner A P, Gage B F. Effect of VKORC1 haplotypeson transcriptional regulation and warfarin dose. N Engl J Med, 2005, 352(22): 2285–2293

doi: 10.1056/NEJMoa044503
[1] Jiangbo Du,Wenjie Xue,Yong Ji,Xun Zhu,Yayun Gu,Meng Zhu,Cheng Wang,Yong Gao,Juncheng Dai,Hongxia Ma,Yue Jiang,Jiaping Chen,Zhibin Hu,Guangfu Jin,Hongbing Shen. U-shaped association between telomere length and esophageal squamous cell carcinoma risk: a case-control study in Chinese population[J]. Front. Med., 2015, 9(4): 478-486.
[2] Tao Wang,Weiping Jia,Cheng Hu. Advancement in genetic variants conferring obesity susceptibility from genome-wide association studies[J]. Front. Med., 2015, 9(2): 146-161.
[3] Yingchen Li,Guoheng Hu,Qilai Cheng. Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges[J]. Front. Med., 2015, 9(1): 20-29.
[4] Ching-Hon Pui. Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia[J]. Front. Med., 2015, 9(1): 1-9.
[5] Xuejun Zhang. Exome sequencing greatly expedites the progressive research of Mendelian diseases[J]. Front Med, 2014, 8(1): 42-57.
[6] Xiaohong Duan, Thomas Markello, David Adams, Camilo Toro, Cynthia Tifft, William A. Gahl, Cornelius F. Boerkoel. Cultural differences define diagnosis and genomic medicine practice: implications for undiagnosed diseases program in China[J]. Front Med, 2013, 7(3): 389-394.
[7] Sandy Leung-Kuen Au, Irene Oi-Lin Ng, Chun-Ming Wong. Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins[J]. Front Med, 2013, 7(2): 231-241.
[8] Qingqing Xu, Xi Wu, Yuyu Xiong, Qinghe Xing, Lin He, Shengying Qin. Pharmacogenomics can improve antipsychotic treatment in schizophrenia[J]. Front Med, 2013, 7(2): 180-190.
[9] Xiao-Mei ZHANG, Ming-Zhou GUO, . The value of epigenetic markers in esophageal cancer[J]. Front. Med., 2010, 4(4): 378-384.
[10] Zi-Jiang CHEN, Yuhua SHI. Polycystic ovary syndrome[J]. Front Med Chin, 2010, 4(3): 280-284.
[11] Dai-Hai YU PhD, Jian-Feng HUANG MD, Ji-Chun CHEN MS, Jie CAO MS, Shu-Feng CHEN PhD, Dong-Feng GU MD, PhD, for the GenSalt Collaborative Research Group, De-Pei LIU PhD, Lai-Yuan WANG PhD, Jing CHEN MD, MSc, Jiang HE MD, PhD, Cashell E. JAQUISH PhD, Dabeeru C. RAO PhD, Charles GU PhD, James E. HIXSON PhD, Chung-Shiuan CHEN MS8, Paul K. WHELTON MD, MSc9, . Genetic variants in the ADD1 and GNB3 genes and blood pressure response to potassium supplementation[J]. Front. Med., 2010, 4(1): 59-66.
[12] ZOU Qilian, LIN Ying, LIN Xiangquan, CHEN Yuanzhong. Genetics analysis of haptoglobin gene in Fujian Han nationality[J]. Front. Med., 2008, 2(1): 105-107.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed